The effect of caffeinated versus decaffeinated drinks on overactive bladder

This data was imported from PubMed:

Authors: Wells, M.J., Jamieson, K., Markham, T.C.W., Green, S.M. and Fader, M.J.

Journal: J Wound Ostomy Continence Nurs

Volume: 41

Issue: 4

Pages: 371-378

eISSN: 1528-3976

DOI: 10.1097/WON.0000000000000040

PURPOSE: The primary aims of this study were to test the methodology for use in a future randomized control trial and to investigate the effect of drinking caffeinated versus decaffeinated fluids on symptoms of overactive bladder (OAB) in women. DESIGN: A double-blind, randomized, crossover study was conducted. METHODS: Fourteen community-dwelling women newly diagnosed with OAB and a history of caffeine consumption were randomly allocated to group A (14-day caffeinated drink period followed by 14-day decaffeinated drink period) or group B (14-day decaffeinated drink period followed by 14-day caffeinated drink period). The periods were preceded by a 14-day run-in period and interspersed with a 14-day washout period. Primary outcomes were episodes of urgency, frequency, volume per void, and incontinence obtained each period on 3-day bladder diaries. Secondary outcome measures were OAB symptom severity and health-related quality of life (QOL) recorded each period using International Consultation on Incontinence-Overactive Bladder Module (ICIQ-OAB) and ICIQ-OAB-Quality of Life (ICIQ-OABqol) tools. Effects of caffeine reduction were measured each day using visual analogue scales. RESULTS: Eleven participants completed the study. A significant reduction in urgency (P < .01) and frequency (P < .05) of urinary voids on day 3 of the diary, total ICIQ-OAB score (P < .01), and a non-significant directional change for the total ICIQ-OABqol score (P = .065) was found using sign tests for the period of decaffeinated compared to caffeinated drink intake. No significant differences were found for any caffeine withdrawal measures. CONCLUSIONS: Despite the small sample size, this pilot study demonstrated that reducing caffeine intake may alleviate the severity of some symptoms and health-related QOL factors associated with OAB. Furthermore, caffeine substitutes were well tolerated.

This data was imported from Scopus:

Authors: Wells, M.J., Jamieson, K., Markham, T.C.W., Green, S.M. and Fader, M.J.

Journal: Journal of Wound, Ostomy and Continence Nursing

Volume: 41

Issue: 4

Pages: 371-378

ISSN: 1071-5754

DOI: 10.1097/WON.0000000000000040

PURPOSE:: The primary aims of this study were to test the methodology for use in a future randomized control trial and to investigate the effect of drinking caffeinated versus decaffeinated fluids on symptoms of overactive bladder (OAB) in women. DESIGN:: A double-blind, randomized, crossover study was conducted. METHODS:: Fourteen community-dwelling women newly diagnosed with OAB and a history of caffeine consumption were randomly allocated to group A (14-day caffeinated drink period followed by 14-day decaffeinated drink period) or group B (14-day decaffeinated drink period followed by 14-day caffeinated drink period). The periods were preceded by a 14-day run-in period and interspersed with a 14-day washout period. Primary outcomes were episodes of urgency, frequency, volume per void, and incontinence obtained each period on 3-day bladder diaries. Secondary outcome measures were OAB symptom severity and health-related quality of life (QOL) recorded each period using International Consultation on Incontinence-Overactive Bladder Module (ICIQ-OAB) and ICIQ-OAB-Quality of Life (ICIQ-OABqol) tools. Effects of caffeine reduction were measured each day using visual analogue scales. RESULTS:: Eleven participants completed the study. A significant reduction in urgency (P < .01) and frequency (P < .05) of urinary voids on day 3 of the diary, total ICIQ-OAB score (P < .01), and a non-significant directional change for the total ICIQ-OABqol score (P = .065) was found using sign tests for the period of decaffeinated compared to caffeinated drink intake. No significant differences were found for any caffeine withdrawal measures. CONCLUSIONS:: Despite the small sample size, this pilot study demonstrated that reducing caffeine intake may alleviate the severity of some symptoms and health-related QOL factors associated with OAB. Furthermore, caffeine substitutes were well tolerated. Copyright © 2014 Wound, Ostomy and Continence Nurses Society™.

This data was imported from Web of Science (Lite):

Authors: Wells, M.J., Jamieson, K., Markham, T.C.W., Green, S.M. and Fader, M.J.

Journal: JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING

Volume: 41

Issue: 4

Pages: 371-378

eISSN: 1528-3976

ISSN: 1071-5754

DOI: 10.1097/WON.0000000000000040

The data on this page was last updated at 05:17 on May 25, 2020.